These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2523411)

  • 1. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.
    Gewirtz AM; Calabretta B; Rucinski B; Niewiarowski S; Xu WY
    J Clin Invest; 1989 May; 83(5):1477-86. PubMed ID: 2523411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro.
    Han ZC; Sensébe L; Abgrall JF; Brière J
    Blood; 1990 Mar; 75(6):1234-9. PubMed ID: 2310823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura.
    Han ZC; Bellucci S; Tenza D; Caen JP
    Br J Haematol; 1990 Apr; 74(4):395-401. PubMed ID: 2140694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine regulation of human megakaryocytopoiesis.
    Gewirtz AM; Zhang J; Ratajczak J; Ratajczak M; Park KS; Li C; Yan Z; Poncz M
    Blood; 1995 Oct; 86(7):2559-67. PubMed ID: 7670101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III).
    Han ZC; Bellucci S; Walz A; Baggiolini M; Caen JP
    Int J Cell Cloning; 1990 Jul; 8(4):253-9. PubMed ID: 2401804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of highly purified human platelet beta-thromboglobulin on in vitro human megakaryocyte colony formation.
    Abgrall JF; Han ZC; Sensebe L; Le Gall G; Guern G; Renard I; Briere J
    Exp Hematol; 1991 Mar; 19(3):202-5. PubMed ID: 1825299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin.
    Lebeurier I; Basara N; Aïdoudi S; Amiral J; Caen JP; Han ZC
    Br J Haematol; 1996 Jan; 92(1):29-34. PubMed ID: 8562407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
    Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC
    Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines.
    Lebeurier I; Raclet L; Amiral J; Caen JP; Han ZC
    J Lab Clin Med; 1996 Feb; 127(2):179-85. PubMed ID: 8636646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents.
    Han ZC; Lu M; Li J; Defard M; Boval B; Schlegel N; Caen JP
    Blood; 1997 Apr; 89(7):2328-35. PubMed ID: 9116276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
    Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
    Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: comparative studies with transforming growth factor beta1.
    Xi X; Caen JP; Fournier S; Schlegel N; Amiral J; Sibony O; Blot P; Han ZC
    Br J Haematol; 1996 May; 93(2):265-72. PubMed ID: 8639415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of thrombopoietic-stimulatory factor and spleen cell-conditioned medium on megakaryocytopoiesis in a short-term bone marrow liquid culture system.
    Petursson SR; Chervenick PA
    Exp Hematol; 1988 Sep; 16(8):660-6. PubMed ID: 3261250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.
    Lambert MP; Rauova L; Bailey M; Sola-Visner MC; Kowalska MA; Poncz M
    Blood; 2007 Aug; 110(4):1153-60. PubMed ID: 17495129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.
    Han ZC; Maurer AM; Bellucci S; Wan HY; Kroviarski Y; Bertrand O; Caen JP
    J Lab Clin Med; 1992 Oct; 120(4):645-60. PubMed ID: 1402341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of human megakaryocytopoiesis.
    Han ZC; Bellucci S; Caen JP
    Nouv Rev Fr Hematol (1978); 1990; 32(6):395-6. PubMed ID: 2101871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.
    Straneva JE; Briddell RA; McDonald TP; Yang HH; Hoffman R
    Exp Hematol; 1989 Dec; 17(11):1122-7. PubMed ID: 2684680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the regulation of human megakaryocytopoiesis.
    Hoffman R; Straneva J; Yang HH; Bruno E; Brandt J
    Blood Cells; 1987; 13(1-2):75-86. PubMed ID: 3499196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].
    Han ZC; Zhang XJ; Xi XD; Lu M; Jiang S; Jiang LZ; Wang XM; Gu GL; Caen JP
    Shi Yan Sheng Wu Xue Bao; 1995 Dec; 28(4):415-26. PubMed ID: 8731973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.